Industry Research Reports

Home > Reports > Chemical & Material > Global Dutasteride API Market Insights, Forecast to 2030

Global Dutasteride API Market Insights, Forecast to 2030

Industry: Chemical & Material

Published Date: 2024-04-15

Pages: 112 Pages

Report ld: 2839799

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.

The global Dutasteride API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dutasteride API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Dutasteride API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Dutasteride API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Dutasteride API include Dr. Reddy’s Laboratories Ltd., Gonane Pharma, Sterling Spa, Stermone Chemicals, Hubei Gedian Humanwell Pharmaceutical Co.,Ltd., Gador SA, Cipla, Zhejiang Xianju Junye Pharmaceutical Co., Ltd. and Aspen Biopharma Labs, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

In terms of production side, this report researches the Dutasteride API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Dutasteride API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for Dutasteride API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Dutasteride API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Dutasteride API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dutasteride API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dutasteride API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dutasteride API sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Dr. Reddy’s Laboratories Ltd.
Gonane Pharma
Sterling Spa
Stermone Chemicals
Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.
Gador SA
Cipla
Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
Aspen Biopharma Labs
Chongqing Huapont Pharmaceutical
Swati Spentose Pvt.Ltd.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity≥98%
Purity<98%

Segment by Application

Dutasteride Tablets
Dutasteride Capsules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Dutasteride API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Dutasteride API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dutasteride API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dutasteride API sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Dutasteride API Product Introduction

1.2 Market by Type

1.2.1 Global Dutasteride API Market Size by Type, 2019 VS 2023 VS 2030

1.2.2 Purity≥98%

1.2.3 Purity<98%

1.3 Market by Application

1.3.1 Global Dutasteride API Market Size by Application, 2019 VS 2023 VS 2030

1.3.2 Dutasteride Tablets

1.3.3 Dutasteride Capsules

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Dutasteride API Production

2.1 Global Dutasteride API Production Capacity (2019-2030)

2.2 Global Dutasteride API Production by Region: 2019 VS 2023 VS 2030

2.3 Global Dutasteride API Production by Region

2.3.1 Global Dutasteride API Historic Production by Region (2019-2024)

2.3.2 Global Dutasteride API Forecasted Production by Region (2025-2030)

2.3.3 Global Dutasteride API Production Market Share by Region (2019-2030)

2.4 Europe

2.5 China

2.6 India

2.7 Japan

3 Executive Summary

3.1 Global Dutasteride API Revenue Estimates and Forecasts 2019-2030

3.2 Global Dutasteride API Revenue by Region

3.2.1 Global Dutasteride API Revenue by Region: 2019 VS 2023 VS 2030

3.2.2 Global Dutasteride API Revenue by Region (2019-2024)

3.2.3 Global Dutasteride API Revenue by Region (2025-2030)

3.2.4 Global Dutasteride API Revenue Market Share by Region (2019-2030)

3.3 Global Dutasteride API Sales Estimates and Forecasts 2019-2030

3.4 Global Dutasteride API Sales by Region

3.4.1 Global Dutasteride API Sales by Region: 2019 VS 2023 VS 2030

3.4.2 Global Dutasteride API Sales by Region (2019-2024)

3.4.3 Global Dutasteride API Sales by Region (2025-2030)

3.4.4 Global Dutasteride API Sales Market Share by Region (2019-2030)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

4.1 Global Dutasteride API Sales by Manufacturers

4.1.1 Global Dutasteride API Sales by Manufacturers (2019-2024)

4.1.2 Global Dutasteride API Sales Market Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dutasteride API in 2023

4.2 Global Dutasteride API Revenue by Manufacturers

4.2.1 Global Dutasteride API Revenue by Manufacturers (2019-2024)

4.2.2 Global Dutasteride API Revenue Market Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Dutasteride API Revenue in 2023

4.3 Global Dutasteride API Sales Price by Manufacturers

4.4 Global Key Players of Dutasteride API, Industry Ranking, 2022 VS 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Dutasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Dutasteride API, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Dutasteride API, Product Offered and Application

4.8 Global Key Manufacturers of Dutasteride API, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Dutasteride API Sales by Type

5.1.1 Global Dutasteride API Historical Sales by Type (2019-2024)

5.1.2 Global Dutasteride API Forecasted Sales by Type (2025-2030)

5.1.3 Global Dutasteride API Sales Market Share by Type (2019-2030)

5.2 Global Dutasteride API Revenue by Type

5.2.1 Global Dutasteride API Historical Revenue by Type (2019-2024)

5.2.2 Global Dutasteride API Forecasted Revenue by Type (2025-2030)

5.2.3 Global Dutasteride API Revenue Market Share by Type (2019-2030)

5.3 Global Dutasteride API Price by Type

5.3.1 Global Dutasteride API Price by Type (2019-2024)

5.3.2 Global Dutasteride API Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global Dutasteride API Sales by Application

6.1.1 Global Dutasteride API Historical Sales by Application (2019-2024)

6.1.2 Global Dutasteride API Forecasted Sales by Application (2025-2030)

6.1.3 Global Dutasteride API Sales Market Share by Application (2019-2030)

6.2 Global Dutasteride API Revenue by Application

6.2.1 Global Dutasteride API Historical Revenue by Application (2019-2024)

6.2.2 Global Dutasteride API Forecasted Revenue by Application (2025-2030)

6.2.3 Global Dutasteride API Revenue Market Share by Application (2019-2030)

6.3 Global Dutasteride API Price by Application

6.3.1 Global Dutasteride API Price by Application (2019-2024)

6.3.2 Global Dutasteride API Price Forecast by Application (2025-2030)

7 US & Canada

7.1 US & Canada Dutasteride API Market Size by Type

7.1.1 US & Canada Dutasteride API Sales by Type (2019-2030)

7.1.2 US & Canada Dutasteride API Revenue by Type (2019-2030)

7.2 US & Canada Dutasteride API Market Size by Application

7.2.1 US & Canada Dutasteride API Sales by Application (2019-2030)

7.2.2 US & Canada Dutasteride API Revenue by Application (2019-2030)

7.3 US & Canada Dutasteride API Sales by Country

7.3.1 US & Canada Dutasteride API Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 US & Canada Dutasteride API Sales by Country (2019-2030)

7.3.3 US & Canada Dutasteride API Revenue by Country (2019-2030)

7.3.4 U.S.

7.3.5 Canada

8 Europe

8.1 Europe Dutasteride API Market Size by Type

8.1.1 Europe Dutasteride API Sales by Type (2019-2030)

8.1.2 Europe Dutasteride API Revenue by Type (2019-2030)

8.2 Europe Dutasteride API Market Size by Application

8.2.1 Europe Dutasteride API Sales by Application (2019-2030)

8.2.2 Europe Dutasteride API Revenue by Application (2019-2030)

8.3 Europe Dutasteride API Sales by Country

8.3.1 Europe Dutasteride API Revenue by Country: 2019 VS 2023 VS 2030

8.3.2 Europe Dutasteride API Sales by Country (2019-2030)

8.3.3 Europe Dutasteride API Revenue by Country (2019-2030)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China Dutasteride API Market Size by Type

9.1.1 China Dutasteride API Sales by Type (2019-2030)

9.1.2 China Dutasteride API Revenue by Type (2019-2030)

9.2 China Dutasteride API Market Size by Application

9.2.1 China Dutasteride API Sales by Application (2019-2030)

9.2.2 China Dutasteride API Revenue by Application (2019-2030)

10 Asia (excluding China)

10.1 Asia Dutasteride API Market Size by Type

10.1.1 Asia Dutasteride API Sales by Type (2019-2030)

10.1.2 Asia Dutasteride API Revenue by Type (2019-2030)

10.2 Asia Dutasteride API Market Size by Application

10.2.1 Asia Dutasteride API Sales by Application (2019-2030)

10.2.2 Asia Dutasteride API Revenue by Application (2019-2030)

10.3 Asia Dutasteride API Sales by Region

10.3.1 Asia Dutasteride API Revenue by Region: 2019 VS 2023 VS 2030

10.3.2 Asia Dutasteride API Revenue by Region (2019-2030)

10.3.3 Asia Dutasteride API Sales by Region (2019-2030)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Dutasteride API Market Size by Type

11.1.1 Middle East, Africa and Latin America Dutasteride API Sales by Type (2019-2030)

11.1.2 Middle East, Africa and Latin America Dutasteride API Revenue by Type (2019-2030)

11.2 Middle East, Africa and Latin America Dutasteride API Market Size by Application

11.2.1 Middle East, Africa and Latin America Dutasteride API Sales by Application (2019-2030)

11.2.2 Middle East, Africa and Latin America Dutasteride API Revenue by Application (2019-2030)

11.3 Middle East, Africa and Latin America Dutasteride API Sales by Country

11.3.1 Middle East, Africa and Latin America Dutasteride API Revenue by Country: 2019 VS 2023 VS 2030

11.3.2 Middle East, Africa and Latin America Dutasteride API Revenue by Country (2019-2030)

11.3.3 Middle East, Africa and Latin America Dutasteride API Sales by Country (2019-2030)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profiles

12.1 Dr. Reddy’s Laboratories Ltd.

12.1.1 Dr. Reddy’s Laboratories Ltd. Company Information

12.1.2 Dr. Reddy’s Laboratories Ltd. Overview

12.1.3 Dr. Reddy’s Laboratories Ltd. Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.1.4 Dr. Reddy’s Laboratories Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments

12.2 Gonane Pharma

12.2.1 Gonane Pharma Company Information

12.2.2 Gonane Pharma Overview

12.2.3 Gonane Pharma Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.2.4 Gonane Pharma Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 Gonane Pharma Recent Developments

12.3 Sterling Spa

12.3.1 Sterling Spa Company Information

12.3.2 Sterling Spa Overview

12.3.3 Sterling Spa Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.3.4 Sterling Spa Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Sterling Spa Recent Developments

12.4 Stermone Chemicals

12.4.1 Stermone Chemicals Company Information

12.4.2 Stermone Chemicals Overview

12.4.3 Stermone Chemicals Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.4.4 Stermone Chemicals Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Stermone Chemicals Recent Developments

12.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.

12.5.1 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Company Information

12.5.2 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Overview

12.5.3 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.5.4 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Developments

12.6 Gador SA

12.6.1 Gador SA Company Information

12.6.2 Gador SA Overview

12.6.3 Gador SA Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.6.4 Gador SA Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Gador SA Recent Developments

12.7 Cipla

12.7.1 Cipla Company Information

12.7.2 Cipla Overview

12.7.3 Cipla Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.7.4 Cipla Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Cipla Recent Developments

12.8 Zhejiang Xianju Junye Pharmaceutical Co., Ltd.

12.8.1 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Company Information

12.8.2 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Overview

12.8.3 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.8.4 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Developments

12.9 Aspen Biopharma Labs

12.9.1 Aspen Biopharma Labs Company Information

12.9.2 Aspen Biopharma Labs Overview

12.9.3 Aspen Biopharma Labs Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.9.4 Aspen Biopharma Labs Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Aspen Biopharma Labs Recent Developments

12.10 Chongqing Huapont Pharmaceutical

12.10.1 Chongqing Huapont Pharmaceutical Company Information

12.10.2 Chongqing Huapont Pharmaceutical Overview

12.10.3 Chongqing Huapont Pharmaceutical Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.10.4 Chongqing Huapont Pharmaceutical Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 Chongqing Huapont Pharmaceutical Recent Developments

12.11 Swati Spentose Pvt.Ltd.

12.11.1 Swati Spentose Pvt.Ltd. Company Information

12.11.2 Swati Spentose Pvt.Ltd. Overview

12.11.3 Swati Spentose Pvt.Ltd. Dutasteride API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.11.4 Swati Spentose Pvt.Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 Swati Spentose Pvt.Ltd. Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Dutasteride API Industry Chain Analysis

13.2 Dutasteride API Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Dutasteride API Production Mode & Process

13.4 Dutasteride API Sales and Marketing

13.4.1 Dutasteride API Sales Channels

13.4.2 Dutasteride API Distributors

13.5 Dutasteride API Customers

14 Dutasteride API Market Dynamics

14.1 Dutasteride API Industry Trends

14.2 Dutasteride API Market Drivers

14.3 Dutasteride API Market Challenges

14.4 Dutasteride API Market Restraints

15 Key Finding in The Global Dutasteride API Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Dutasteride API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Purity≥98%

Table 3. Major Manufacturers of Purity<98%

Table 4. Global Dutasteride API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Dutasteride API Production by Region: 2019 VS 2023 VS 2030 (Ton)

Table 6. Global Dutasteride API Production by Region (2019-2024) & (Ton)

Table 7. Global Dutasteride API Production by Region (2025-2030) & (Ton)

Table 8. Global Dutasteride API Production Market Share by Region (2019-2024)

Table 9. Global Dutasteride API Production Market Share by Region (2025-2030)

Table 10. Global Dutasteride API Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Dutasteride API Revenue by Region (2019-2024) & (US$ Million)

Table 12. Global Dutasteride API Revenue by Region (2025-2030) & (US$ Million)

Table 13. Global Dutasteride API Revenue Market Share by Region (2019-2024)

Table 14. Global Dutasteride API Revenue Market Share by Region (2025-2030)

Table 15. Global Dutasteride API Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Dutasteride API Sales by Region (2019-2024) & (Ton)

Table 17. Global Dutasteride API Sales by Region (2025-2030) & (Ton)

Table 18. Global Dutasteride API Sales Market Share by Region (2019-2024)

Table 19. Global Dutasteride API Sales Market Share by Region (2025-2030)

Table 20. Global Dutasteride API Sales by Manufacturers (2019-2024) & (Ton)

Table 21. Global Dutasteride API Sales Share by Manufacturers (2019-2024)

Table 22. Global Dutasteride API Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 23. Global Dutasteride API Revenue Share by Manufacturers (2019-2024)

Table 24. Dutasteride API Price by Manufacturers 2019-2024 (US$/Ton)

Table 25. Global Key Players of Dutasteride API, Industry Ranking, 2022 VS 2023 VS 2024

Table 26. Global Dutasteride API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Dutasteride API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride API as of 2023)

Table 28. Global Key Manufacturers of Dutasteride API, Manufacturing Base Distribution and Headquarters

Table 29. Global Key Manufacturers of Dutasteride API, Product Offered and Application

Table 30. Global Key Manufacturers of Dutasteride API, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 33. Global Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 34. Global Dutasteride API Sales Share by Type (2019-2024)

Table 35. Global Dutasteride API Sales Share by Type (2025-2030)

Table 36. Global Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 37. Global Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 38. Global Dutasteride API Revenue Share by Type (2019-2024)

Table 39. Global Dutasteride API Revenue Share by Type (2025-2030)

Table 40. Dutasteride API Price by Type (2019-2024) & (US$/Ton)

Table 41. Global Dutasteride API Price Forecast by Type (2025-2030) & (US$/Ton)

Table 42. Global Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 43. Global Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 44. Global Dutasteride API Sales Share by Application (2019-2024)

Table 45. Global Dutasteride API Sales Share by Application (2025-2030)

Table 46. Global Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 47. Global Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 48. Global Dutasteride API Revenue Share by Application (2019-2024)

Table 49. Global Dutasteride API Revenue Share by Application (2025-2030)

Table 50. Dutasteride API Price by Application (2019-2024) & (US$/Ton)

Table 51. Global Dutasteride API Price Forecast by Application (2025-2030) & (US$/Ton)

Table 52. US & Canada Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 53. US & Canada Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 54. US & Canada Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 55. US & Canada Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 56. US & Canada Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 57. US & Canada Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 58. US & Canada Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 59. US & Canada Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 60. US & Canada Dutasteride API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 61. US & Canada Dutasteride API Revenue by Country (2019-2024) & (US$ Million)

Table 62. US & Canada Dutasteride API Revenue by Country (2025-2030) & (US$ Million)

Table 63. US & Canada Dutasteride API Sales by Country (2019-2024) & (Ton)

Table 64. US & Canada Dutasteride API Sales by Country (2025-2030) & (Ton)

Table 65. Europe Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 66. Europe Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 67. Europe Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 68. Europe Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 69. Europe Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 70. Europe Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 71. Europe Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 72. Europe Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 73. Europe Dutasteride API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 74. Europe Dutasteride API Revenue by Country (2019-2024) & (US$ Million)

Table 75. Europe Dutasteride API Revenue by Country (2025-2030) & (US$ Million)

Table 76. Europe Dutasteride API Sales by Country (2019-2024) & (Ton)

Table 77. Europe Dutasteride API Sales by Country (2025-2030) & (Ton)

Table 78. China Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 79. China Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 80. China Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 81. China Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 82. China Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 83. China Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 84. China Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 85. China Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 86. Asia Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 87. Asia Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 88. Asia Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 89. Asia Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 90. Asia Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 91. Asia Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 92. Asia Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 93. Asia Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 94. Asia Dutasteride API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 95. Asia Dutasteride API Revenue by Region (2019-2024) & (US$ Million)

Table 96. Asia Dutasteride API Revenue by Region (2025-2030) & (US$ Million)

Table 97. Asia Dutasteride API Sales by Region (2019-2024) & (Ton)

Table 98. Asia Dutasteride API Sales by Region (2025-2030) & (Ton)

Table 99. Middle East, Africa and Latin America Dutasteride API Sales by Type (2019-2024) & (Ton)

Table 100. Middle East, Africa and Latin America Dutasteride API Sales by Type (2025-2030) & (Ton)

Table 101. Middle East, Africa and Latin America Dutasteride API Revenue by Type (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Dutasteride API Revenue by Type (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Dutasteride API Sales by Application (2019-2024) & (Ton)

Table 104. Middle East, Africa and Latin America Dutasteride API Sales by Application (2025-2030) & (Ton)

Table 105. Middle East, Africa and Latin America Dutasteride API Revenue by Application (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Dutasteride API Revenue by Application (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Dutasteride API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 108. Middle East, Africa and Latin America Dutasteride API Revenue by Country (2019-2024) & (US$ Million)

Table 109. Middle East, Africa and Latin America Dutasteride API Revenue by Country (2025-2030) & (US$ Million)

Table 110. Middle East, Africa and Latin America Dutasteride API Sales by Country (2019-2024) & (Ton)

Table 111. Middle East, Africa and Latin America Dutasteride API Sales by Country (2025-2030) & (Ton)

Table 112. Dr. Reddy’s Laboratories Ltd. Company Information

Table 113. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses

Table 114. Dr. Reddy’s Laboratories Ltd. Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. Dr. Reddy’s Laboratories Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Dr. Reddy’s Laboratories Ltd. Recent Development

Table 117. Gonane Pharma Company Information

Table 118. Gonane Pharma Description and Major Businesses

Table 119. Gonane Pharma Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. Gonane Pharma Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Gonane Pharma Recent Development

Table 122. Sterling Spa Company Information

Table 123. Sterling Spa Description and Major Businesses

Table 124. Sterling Spa Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 125. Sterling Spa Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Sterling Spa Recent Development

Table 127. Stermone Chemicals Company Information

Table 128. Stermone Chemicals Description and Major Businesses

Table 129. Stermone Chemicals Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 130. Stermone Chemicals Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Stermone Chemicals Recent Development

Table 132. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Company Information

Table 133. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Description and Major Businesses

Table 134. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 135. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Development

Table 137. Gador SA Company Information

Table 138. Gador SA Description and Major Businesses

Table 139. Gador SA Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 140. Gador SA Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Gador SA Recent Development

Table 142. Cipla Company Information

Table 143. Cipla Description and Major Businesses

Table 144. Cipla Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 145. Cipla Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Cipla Recent Development

Table 147. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Company Information

Table 148. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Description and Major Businesses

Table 149. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 150. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Development

Table 152. Aspen Biopharma Labs Company Information

Table 153. Aspen Biopharma Labs Description and Major Businesses

Table 154. Aspen Biopharma Labs Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 155. Aspen Biopharma Labs Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Aspen Biopharma Labs Recent Development

Table 157. Chongqing Huapont Pharmaceutical Company Information

Table 158. Chongqing Huapont Pharmaceutical Description and Major Businesses

Table 159. Chongqing Huapont Pharmaceutical Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 160. Chongqing Huapont Pharmaceutical Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Chongqing Huapont Pharmaceutical Recent Development

Table 162. Swati Spentose Pvt.Ltd. Company Information

Table 163. Swati Spentose Pvt.Ltd. Description and Major Businesses

Table 164. Swati Spentose Pvt.Ltd. Dutasteride API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 165. Swati Spentose Pvt.Ltd. Dutasteride API Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Swati Spentose Pvt.Ltd. Recent Development

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Dutasteride API Distributors List

Table 170. Dutasteride API Customers List

Table 171. Dutasteride API Market Trends

Table 172. Dutasteride API Market Drivers

Table 173. Dutasteride API Market Challenges

Table 174. Dutasteride API Market Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Dutasteride API Product Picture

Figure 2. Global Dutasteride API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Dutasteride API Market Share by Type in 2023 & 2030

Figure 4. Purity≥98% Product Picture

Figure 5. Purity<98% Product Picture

Figure 6. Global Dutasteride API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Dutasteride API Market Share by Application in 2023 & 2030

Figure 8. Dutasteride Tablets

Figure 9. Dutasteride Capsules

Figure 10. Others

Figure 11. Dutasteride API Report Years Considered

Figure 12. Global Dutasteride API Capacity, Production and Utilization (2019-2030) & (Ton)

Figure 13. Global Dutasteride API Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Dutasteride API Production Market Share by Region (2019-2030)

Figure 15. Dutasteride API Production Growth Rate in Europe (2019-2030) & (Ton)

Figure 16. Dutasteride API Production Growth Rate in China (2019-2030) & (Ton)

Figure 17. Dutasteride API Production Growth Rate in India (2019-2030) & (Ton)

Figure 18. Dutasteride API Production Growth Rate in Japan (2019-2030) & (Ton)

Figure 19. Global Dutasteride API Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Dutasteride API Revenue 2019-2030 (US$ Million)

Figure 21. Global Dutasteride API Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 22. Global Dutasteride API Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 23. Global Dutasteride API Revenue Market Share by Region (2019-2030)

Figure 24. Global Dutasteride API Sales 2019-2030 ((Ton)

Figure 25. Global Dutasteride API Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Ton)

Figure 26. Global Dutasteride API Sales Market Share by Region (2019-2030)

Figure 27. US & Canada Dutasteride API Sales YoY (2019-2030) & (Ton)

Figure 28. US & Canada Dutasteride API Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Europe Dutasteride API Sales YoY (2019-2030) & (Ton)

Figure 30. Europe Dutasteride API Revenue YoY (2019-2030) & (US$ Million)

Figure 31. China Dutasteride API Sales YoY (2019-2030) & (Ton)

Figure 32. China Dutasteride API Revenue YoY (2019-2030) & (US$ Million)

Figure 33. Asia (excluding China) Dutasteride API Sales YoY (2019-2030) & (Ton)

Figure 34. Asia (excluding China) Dutasteride API Revenue YoY (2019-2030) & (US$ Million)

Figure 35. Middle East, Africa and Latin America Dutasteride API Sales YoY (2019-2030) & (Ton)

Figure 36. Middle East, Africa and Latin America Dutasteride API Revenue YoY (2019-2030) & (US$ Million)

Figure 37. The Dutasteride API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 38. The Top 5 and 10 Largest Manufacturers of Dutasteride API in the World: Market Share by Dutasteride API Revenue in 2023

Figure 39. Global Dutasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 40. Global Dutasteride API Sales Market Share by Type (2019-2030)

Figure 41. Global Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 42. Global Dutasteride API Sales Market Share by Application (2019-2030)

Figure 43. Global Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Dutasteride API Sales Market Share by Type (2019-2030)

Figure 45. US & Canada Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 46. US & Canada Dutasteride API Sales Market Share by Application (2019-2030)

Figure 47. US & Canada Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 48. US & Canada Dutasteride API Revenue Share by Country (2019-2030)

Figure 49. US & Canada Dutasteride API Sales Share by Country (2019-2030)

Figure 50. U.S. Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 51. Canada Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 52. Europe Dutasteride API Sales Market Share by Type (2019-2030)

Figure 53. Europe Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 54. Europe Dutasteride API Sales Market Share by Application (2019-2030)

Figure 55. Europe Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 56. Europe Dutasteride API Revenue Share by Country (2019-2030)

Figure 57. Europe Dutasteride API Sales Share by Country (2019-2030)

Figure 58. Germany Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 59. France Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 60. U.K. Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 61. Italy Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 62. Russia Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 63. China Dutasteride API Sales Market Share by Type (2019-2030)

Figure 64. China Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 65. China Dutasteride API Sales Market Share by Application (2019-2030)

Figure 66. China Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 67. Asia Dutasteride API Sales Market Share by Type (2019-2030)

Figure 68. Asia Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 69. Asia Dutasteride API Sales Market Share by Application (2019-2030)

Figure 70. Asia Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 71. Asia Dutasteride API Revenue Share by Region (2019-2030)

Figure 72. Asia Dutasteride API Sales Share by Region (2019-2030)

Figure 73. Japan Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 74. South Korea Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 75. China Taiwan Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 76. Southeast Asia Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 77. India Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 78. Middle East, Africa and Latin America Dutasteride API Sales Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Dutasteride API Revenue Market Share by Type (2019-2030)

Figure 80. Middle East, Africa and Latin America Dutasteride API Sales Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Dutasteride API Revenue Market Share by Application (2019-2030)

Figure 82. Middle East, Africa and Latin America Dutasteride API Revenue Share by Country (2019-2030)

Figure 83. Middle East, Africa and Latin America Dutasteride API Sales Share by Country (2019-2030)

Figure 84. Brazil Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 85. Mexico Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 86. Turkey Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 87. Israel Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 88. GCC Countries Dutasteride API Revenue (2019-2030) & (US$ Million)

Figure 89. Dutasteride API Value Chain

Figure 90. Dutasteride API Production Process

Figure 91. Channels of Distribution

Figure 92. Distributors Profiles

Figure 93. Bottom-up and Top-down Approaches for This Report

Figure 94. Data Triangulation

Figure 95. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Dutasteride API market? zhanKai

The top companies in the global Dutasteride API market are Dr. Reddy’s Laboratories Ltd.、Gonane Pharma、Sterling Spa.

Related Reports

Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dutasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 145
USD 3950.00
(Single User License)
Global Dutasteride API Market Research Report 2026
The global Dutasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 144
USD 2900.00
(Single User License)
Global Dutasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dutasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 155
USD 4900.00
(Single User License)
Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dutasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 128
USD 3950.00
(Single User License)
Global Dutasteride API Market Research Report 2025
The global market for Dutasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
Global Dutasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dutasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 96
USD 4250.00
(Single User License)
Dutasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published Date: 2024-02-23
Pages: 125
USD 3950.00
(Single User License)
Global Dutasteride API Market Research Report 2024
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published Date: 2024-01-10
Pages: 103
USD 2900.00
(Single User License)

Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dutasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 145
USD 3950.00 (Single User License)
Global Dutasteride API Market Research Report 2026
The global Dutasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 144
USD 2900.00 (Single User License)
Global Dutasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dutasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 155
USD 4900.00 (Single User License)
Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dutasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 128
USD 3950.00 (Single User License)
Global Dutasteride API Market Research Report 2025
The global market for Dutasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 96
USD 2900.00 (Single User License)
Global Dutasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dutasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 96
USD 4250.00 (Single User License)
Dutasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published: 2024-02-23
Pages: 125
USD 3950.00 (Single User License)
Global Dutasteride API Market Research Report 2024
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published: 2024-01-10
Pages: 103
USD 2900.00 (Single User License)